Synthesis of antimicrobial natural products targeting FtsZ: (±)-dichamanetin and (±)-2‴-hydroxy-5″- benzylisouvarinol-B

Organic Letters

Volumn 7, Issue 25, 2005, Pages 5609-5612

  Urgaonkar, Sameer ^a   La Pierre, Henry S ^a   Meir, Israel ^a   Lund, Henrik ^b   RayChaudhuri, Debabrata ^b   Shaw, Jared T ^a  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2''' HYDROXY 5'' BENZYLISOUVARINOL B; 2'''-HYDROXY-5''-BENZYLISOUVARINOL-B; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BIOLOGICAL PRODUCT; CHLORIDE; CYTOSKELETON PROTEIN; DICHAMANETIN; ENZYME INHIBITOR; FLAVANONE DERIVATIVE; FTSZ PROTEIN, BACTERIA; GUANOSINE TRIPHOSPHATASE; ZINC CHLORIDE; ZINC DERIVATIVE;

ARTICLE; CHEMISTRY; CYTOKINESIS; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY; STEREOISOMERISM; SYNTHESIS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOLOGICAL PRODUCTS; CHLORIDES; CYTOKINESIS; CYTOSKELETAL PROTEINS; ENZYME INHIBITORS; FLAVANONES; GTP PHOSPHOHYDROLASES; STEREOISOMERISM; ZINC COMPOUNDS;

EID: 29444442409     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol052269z     Document Type: Article

References (42)

1. (a) Walsh, C. Nat. Rev. Microbiol. 2003, 1, 65-70.
2. (b) Walsh, C.; Wright, G. Chem. Rev. 2005, 105, 391-393.
3. (a) Romberg, L.; Levin, P. A. Annu. Rev. Microbiol. 2003, 57, 125-154.
4. (b) Margolin, W. Curr. Biol. 2003, 13, R16-R18.
5. (c) Addinall, S. G.; Holland, B. J. Mol. Biol. 2002, 318, 219-236.
6. (d) Weiss, D. S. Mol. Microbiol. 2004, 54, 588-597.
7. (e) Errington, J.; Daniel, R. A.; Scheffers, D.-J. Microbiol. Mol. Biol. Rev. 2003, 67, 52-65.
8. (a) Wang, J.; Galgoci, A.; Kodali, S.; Herath, K. B.; Jayasuriya, H.; Dorso, K.; Vicente, F.; Gonzalez, A.; Cully, D.; Bramhill, D.; Singh, S. J. Biol. Chem. 2003, 278, 44424-44428.
9. (b) Reynolds, R. C.; Srivastava, S.; Ross, L. J.; Suling, W. J.; White, E. L. Bioorg. Med. Chem. Lett. 2004, 14, 3161-3164.
10. (c) White, E. L.; Suling, W. J.; Ross, L. J.; Seitz, L. E.; Reynolds, R. C. J. Antimicrob. Chemother. 2002, 50, 111-114.
11. (a) Margalit, D. N.; Romberg, L.; Mets, R. B.; Hebert, A. M.; Mitchison, T. J.; Kirschner, M. W.; RayChaudhuri, D. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 11821-11826.
12. The antibacterial activity of 1 was first noted by Beaver: (b) Beaver, D. J.; Shumard, R. S.; Stoffel, P. J. J. Am. Chem. Soc. 1953, 75, 5579-5581.
13. After Beaver, Hakimelahi made similar observations with 1 and related analogues: (c) Hakimelahi, G. H.; Moshfegh, A. A. Helv. Chim. Acta 1981, 64, 599-609.
14. (d) Moshfegh, A. A.; Badri, R.; Hojjatie, M.; Kaviani, M.; Naderi, B.; Nazmi, A. H.; Ramezanian, M.; Roozpeikar, B.; Hakimelahi, G. H. Helv. Chim. Acta 1982, 65, 1221-1228.
15. (a) Hufford, C. D.; Lasswell, W. L., Jr. Lloydia 1978, 41, 156-160.
16. (b) Anam, E. M. Ind. J. Chem., Sect. B 1994, 33B, 1009-1011. See ref 4a for MIC values of 1.
17. The National Committee for Clinical Laboratory standards (NCCLS) defines the effective MICs of methicillin, erythromycin, and vancomycin as 0.8, 0.4, and 5.8 μM, respectively, against S. aureus. Higher MICs indicate that a strain is becoming resistant to the drug. Leegaard, T. M.; Caugant, D. A.; Frøholm, L. O.; Høiby, E. A. Clin. Microbiol. Infect. 2000, 6, 290-293.
18. The synthesis of gericudranin, a related p-hydroxybenzylated 3-hydroxyflavanone has been reported: Choi, Y.-J.; Shim, P.-J.; Ko, K.-S.; Kim, H.-D. Heterocycles 1996, 43, 1223-1228.
19. Van De Water, R. W.; Pettus, T. R. R. Tetrahedron 2002, 58, 5367-5405.
20. (a) Tabatabai, M.; Vogt, W.; Boehmer, V. Tetrahedron Lett. 1990, 31, 3295-3298.
21. (b) Tabatabai, M.; Vogt, W.; Baehmer, V.; Ferguson, G.; Paulus, E. F. Supramol. Chem. 1994, 4, 147-152.
22. (a) Lee, J.-M.; Tseng, T.-H.; Lee, Y.-J. Synthesis 2001, 2247-2254.
23. (b) Solladie, G.; Gehrold, N.; Maignan, J. Eur. J. Org. Chem. 1999, 2309, 9-2314.
24. (c) Talapatra, B.; Deb, T.; Talapatra, S. Ind. J. Chem., Sect. B 1986, 25B, 1122-1125.
25. (d) Suresh, R. V.; Iyer, C. S. R.; Iyer, P. R. Heterocycles 1986, 24, 1925-1930.
26. Huzise, S.-I.; Tatsita, H. Chem. Ber. 1941, 74B, 275-278.
27. Huang, C.; Li, S.; Hou, L.; Li, Y.; Li, Y. Synth. Commun. 1999, 29, 1383-1392.
28. Zhao, L.; Li, Y. Org. Prep. Proced. Int. 1996, 28, 165-171.
29. (a) Ghantwal, S. R.; Samant, S. D. J. Indian Chem. Soc. 2000, 77, 100-101.
30. (b) Jerzmanowska, Z.; Jurkowska-Kowalczyk, E. Rocz. Chem. 1970, 44, 1395-1401.
31. (a) Hellmann, H.; Pohlmann, J. L. W. Liebigs Ann. Chem. 1961, 642, 28-35.
32. (b) Hellmann, H.; Pohlmann, J. L. W. Liebigs Ann. Chem. 1961, 643, 38-42.
33. Mazzei, M.; Miele, M.; Nieddu, E.; Barbieri, F.; Bruzzo, C.; Alama, A. Eur. J. Med. Chem. 2001, 36, 915-923.
34. Crisp, G. T.; Turner, P. D. Tetrahedron 2000, 56, 407-415.
35. Sinhababu, A. K.; Borchardt, R. T. Synth. Commun. 1983, 13, 677-683.
36. McCamley, K.; Ripper, J. A.; Singer, R. D.; Scammells, P. J. J. Org. Chem. 2003, 68, 9847-9850. While this oxidation may have yielded appreciable amounts of the desired N-oxide, this compound was difficult to handle due to its apparent high aqueous solubility.
37. Baik, W.; Lee, H. J.; Yoo, C. H.; Jung, J. W.; Kim, B. H. J. Chem. Soc., Perkin Trans. 1 1997, 5, 587-589.
38. 2 for this reaction: Lasswell, W. L., Jr.; Hufford, C. D. J. Org. Chem. 1977, 42, 1295-1302.
39. A related process has been reported using phenol-derived, but not resorcinol-derived, substrates. The reported reaction was conducted under conditions using a domestic microwave, and while the temperature was not monitored, the wattage applied suggests that the reaction takes place at >200°C: Khalafi-Nezhad, A.; Rad, M. N. S.; Hakimelahi, G. H. Helv. Chim. Acta 2003, 86, 2396-2403.
40. De Bruyn, P. J.; Foo, L. M.; Lim, A. S. C.; Looney, M. G.; Solomon, D. H. Tetrahedron 1997, 53, 13915-13932.
41. Nagata, W.; Okada, K.; Aoki, T. Synthesis 1979, 365-368.
42. 13C NMR is reported and we were unable to obtain an authentic sample for comparison.